These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 1759508)

  • 41. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines.
    Christy C; Pichichero ME; Reed GF; Decker MD; Anderson EL; Rennels MB; Englund JA; Edwards KM; Steinhoff MC
    Pediatrics; 1995 Sep; 96(3 Pt 2):584-7. PubMed ID: 7659481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
    Morgan CM; Blumberg DA; Cherry JD; Reisinger KS; Blatter MM; Blumer JL; Dekker CL; Stout MG; Christenson PD
    Am J Dis Child; 1990 Jan; 144(1):41-5. PubMed ID: 2403747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of postvaccinal pertussis immunity by using immunoenzyme analysis].
    Khardina AA; Lapaeva IA; Amelina IP; Rusakova EV; Kuliakina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):50-4. PubMed ID: 2540600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
    Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
    Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.
    Taranger J; Trollfors B; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
    Pediatr Infect Dis J; 1997 Feb; 16(2):180-4. PubMed ID: 9041597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.
    Vermeulen F; Verscheure V; Damis E; Vermeylen D; Leloux G; Dirix V; Locht C; Mascart F
    Clin Vaccine Immunol; 2010 Feb; 17(2):258-62. PubMed ID: 20016042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
    Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
    Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses to pertussis vaccines concurrently administered with viral vaccines.
    Halperin SA; Eastwood BJ; Langley JM
    Ann N Y Acad Sci; 1995 May; 754():89-96. PubMed ID: 7625684
    [No Abstract]   [Full Text] [Related]  

  • 52. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
    Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD
    Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results with a new DTP vaccine in Japan.
    Kimura M; Hikino N
    Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of pertussis antibodies among different age groups in Japan.
    Konda T; Kamachi K; Iwaki M; Matsunaga Y
    Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children.
    Lewis K; Cherry JD; Holroyd HJ; Baker LR; Dudenhoeffer FE; Robinson RG
    Am J Dis Child; 1986 Sep; 140(9):872-6. PubMed ID: 2874738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
    Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.